skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

33 studies were found about rifabutin

Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults

Condition: Staphylococcus Aureus; HIV Infections

NCT ID: NCT00869518

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00002080

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001030

Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00000877

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023400

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023348

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001023

Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00018083

A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc

Condition: HIV Infection; HIV-1 Infection; Mycobacterium Avium Complex (MAC)

NCT ID: NCT01894776

Safety And Efficacy Of Rifabutin In HIV Patients

Condition: Non-tuberculous Mycobacterial Diseases (Including MAC Disease); Tuberculosis; Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections

NCT ID: NCT00810446

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023361

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023413

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Condition: Mycoses; Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002122

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002101

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002343

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Condition: Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

NCT ID: NCT01259219

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00002267

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00002032

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Condition: Bacterial Infections; Mycoses; HIV Infections

NCT ID: NCT00000826

A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00001995

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001047

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001058

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Condition: HIV; Tuberculosis

NCT ID: NCT00743470

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01059422

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

Drug Interaction Study

Condition: Antivirals/HIV

NCT ID: NCT00646776

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

Condition: Healthy Volunteers

NCT ID: NCT00925535